Shattuck Labs Inc (STTK) Straddle

Trading a STTK straddle lets you take a pure volatility position on Shattuck Labs Inc without committing to a direction. Shattuck Labs Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate STTK straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on STTK profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Shattuck Labs Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the STTK straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the STTK straddle is the cleanest expression of that view. Our scanner prices every STTK straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a STTK straddle into a catalyst or short a STTK straddle to harvest decay, the options straddle setups that matter are all in one place.